Ashford Capital Management Inc Supernus Pharmaceuticals, Inc. Transaction History

Ashford Capital Management Inc

  • $709 Million
  • Q2 2025

A detailed history of Ashford Capital Management Inc transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Ashford Capital Management Inc holds 574,372 shares of SUPN stock, worth $23.7 Million. This represents 2.55% of its overall portfolio holdings.

Number of Shares
574,372
Previous 566,556 1.38%
Holding current value
$23.7 Million
Previous $18.6 Million 2.43%
% of portfolio
2.55%
Previous 2.83%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 18, 2025
BUY
$30.29 - $33.43 $236,746 - $261,288
7,816 Added 1.38%
574,372 $18.1 Million
Q1 2025

May 15, 2025
BUY
$31.17 - $40.0 $647,743 - $831,240
20,781 Added 3.81%
566,556 $18.6 Million
Q4 2024

Feb 14, 2025
BUY
$31.89 - $37.83 $55,488 - $65,824
1,740 Added 0.32%
545,775 $19.7 Million
Q3 2024

Nov 15, 2024
SELL
$25.77 - $35.16 $4.33 Million - $5.9 Million
-167,859 Reduced 23.58%
544,035 $17 Million
Q2 2024

Aug 15, 2024
SELL
$25.99 - $33.85 $1.34 Million - $1.75 Million
-51,571 Reduced 6.75%
711,894 $19 Million
Q1 2024

May 15, 2024
SELL
$27.11 - $35.17 $1.71 Million - $2.22 Million
-63,023 Reduced 7.63%
763,465 $26 Million
Q4 2023

Feb 14, 2024
SELL
$22.72 - $29.68 $2.05 Million - $2.68 Million
-90,259 Reduced 9.85%
826,488 $23.9 Million
Q3 2023

Nov 15, 2023
SELL
$27.57 - $32.91 $258,165 - $308,169
-9,364 Reduced 1.01%
916,747 $25.3 Million
Q2 2023

Aug 11, 2023
BUY
$29.91 - $38.73 $124,096 - $160,690
4,149 Added 0.45%
926,111 $27.8 Million
Q1 2023

May 15, 2023
SELL
$34.93 - $42.03 $415,247 - $499,652
-11,888 Reduced 1.27%
921,962 $33.4 Million
Q4 2022

Feb 15, 2023
SELL
$31.09 - $37.88 $4.99 Million - $6.08 Million
-160,593 Reduced 14.67%
933,850 $33.3 Million
Q3 2022

Nov 15, 2022
SELL
$28.79 - $35.41 $1.01 Million - $1.24 Million
-34,984 Reduced 3.1%
1,094,443 $37 Million
Q2 2022

Aug 15, 2022
BUY
$25.33 - $34.25 $127,207 - $172,003
5,022 Added 0.45%
1,129,427 $32.7 Million
Q1 2022

May 16, 2022
BUY
$28.51 - $32.9 $1.96 Million - $2.27 Million
68,875 Added 6.53%
1,124,405 $36.3 Million
Q4 2021

Feb 15, 2022
BUY
$26.37 - $34.22 $1.02 Million - $1.33 Million
38,865 Added 3.82%
1,055,530 $30.8 Million
Q3 2021

Nov 15, 2021
BUY
$23.54 - $31.39 $369,413 - $492,603
15,693 Added 1.57%
1,016,665 $27.1 Million
Q2 2021

Aug 26, 2021
SELL
$26.72 - $33.19 $6.15 Million - $7.64 Million
-230,256 Reduced 18.7%
1,000,972 $30.8 Million
Q1 2021

May 14, 2021
BUY
$24.15 - $31.45 $228,869 - $298,051
9,477 Added 0.78%
1,231,228 $32.2 Million
Q4 2020

Feb 16, 2021
BUY
$17.7 - $25.81 $7.16 Million - $10.4 Million
404,247 Added 49.45%
1,221,751 $30.7 Million
Q3 2020

Nov 16, 2020
BUY
$20.2 - $25.05 $2.64 Million - $3.28 Million
130,799 Added 19.05%
817,504 $17 Million
Q2 2020

Aug 17, 2020
BUY
$17.09 - $24.89 $1.89 Million - $2.76 Million
110,701 Added 19.22%
686,705 $16.3 Million
Q1 2020

May 15, 2020
SELL
$14.45 - $24.69 $1.7 Million - $2.9 Million
-117,318 Reduced 16.92%
576,004 $10.4 Million
Q4 2019

Feb 14, 2020
SELL
$19.93 - $29.13 $2.21 Million - $3.24 Million
-111,087 Reduced 13.81%
693,322 $16.4 Million
Q3 2019

Nov 15, 2019
SELL
$25.47 - $33.37 $740,896 - $970,699
-29,089 Reduced 3.49%
804,409 $22.1 Million
Q2 2019

Aug 15, 2019
SELL
$29.96 - $38.87 $101,864 - $132,158
-3,400 Reduced 0.41%
833,498 $27.6 Million
Q1 2019

May 15, 2019
BUY
$32.77 - $41.99 $2.84 Million - $3.64 Million
86,622 Added 11.55%
836,898 $29.3 Million
Q4 2018

Feb 15, 2019
BUY
$30.84 - $49.51 $1.57 Million - $2.52 Million
50,844 Added 7.27%
750,276 $24.9 Million
Q3 2018

Nov 15, 2018
BUY
$42.7 - $56.55 $32,281 - $42,751
756 Added 0.11%
699,432 $35.2 Million
Q2 2018

Aug 15, 2018
SELL
$44.1 - $59.85 $8.03 Million - $10.9 Million
-182,098 Reduced 20.67%
698,676 $41.8 Million
Q1 2018

May 15, 2018
BUY
$37.15 - $46.9 $4.65 Million - $5.87 Million
125,162 Added 16.56%
880,774 $40.3 Million
Q4 2017

Feb 15, 2018
BUY
$36.4 - $42.6 $47,611 - $55,720
1,308 Added 0.17%
755,612 $30.1 Million
Q3 2017

Nov 15, 2017
SELL
$36.75 - $49.65 $67,473 - $91,157
-1,836 Reduced 0.24%
754,304 $30.2 Million
Q2 2017

Aug 21, 2017
BUY
N/A
756,140
756,140 $32.6 Million

Others Institutions Holding SUPN

# of Institutions
311
Shares Held
61.6M
Call Options Held
18.4K
Put Options Held
0
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $2.21B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Ashford Capital Management Inc Portfolio

Follow Ashford Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ashford Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ashford Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email